DTDaniel Tilia

Daniel Tilia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Tilia has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spectacles with non‑refractive opaque features for paediatric myopia: a safety pilot trial

    by Ravi C. Bakaraju, Jennie Diec, Daniel Tilia, Klaus Ehrmann, Ranjay Chakraborty

  • Electroretinographic evaluation of single vision contact lenses with non-refractive opaque features

    by Ravi C Bakaraju, Paul A Constable, Daniel Tilia, Kevin Patel, Ranjay Chakraborty

    Electroretinography provides insights into how optical interventions, e.g., contact lenses (CLs), may influence retinal function. Understanding acute retinal responses is important for the ongoing development of myopia control strategies. To investigate the acute effects of single-vision (test) soft CLs incorporating non-refractive opaque elements on retinal function. These lenses are designed to modulate retinal ganglion cell activity through Active Reconfiguration in Retinal Encoding of Spatio-Temporal signalling with a potential for myopia control. In a randomised, contralateral-eye study, 30 participants (18 to 25 years; refractive error: 0.00D to -5.50D) wore single-vision test and control CLs. Electroretinograms were recorded at baseline, 10, and 40 minutes using red flash stimuli (38 Troland-seconds at 3.8 Hz) on a blue background (380 Trolands). Time-amplitude and Discrete Wavelet Transform analyses quantified changes in retinal response. Metrics included a-wave and b-wave peak times and amplitudes, Photopic Negative Response (PhNR) amplitude and timing, P-ratio, W-ratio, and OFF/ON pathway coefficients. TTest lenses induced significant delays in a-wave (mean difference [MD]: 0.26 ms, p = 0.008) and b-wave (MD: 0.26 ms, p < 0.001) peak times, with no significant amplitude changes. PhNR amplitude was significantly reduced (MD: 0.42 µV, p = 0.01), and peak time was delayed (MD: 0.51 ms, p = 0.02). P ratio (MD: -0.04, p = 0.001), and W-ratio (MD: -0.04, p = 0.004) significantly suppressed with test lenses. Time-frequency analysis revealed selective suppression of OFF-pathway activity (40Hz coefficient, MD: -0.89 µV-s, p = 0.02) with test lenses, while ON-pathway components remained stable. 80Hz oscillatory potentials were significantly reduced with test lenses (MD: -1.35 µV-s, p = 0.02). . Non-refractive opaque features within an otherwise single-vision CL can induce short-term changes in retinal signalling, characterised by temporal shifts in post-receptoral signalling, potentially suggesting pathway-specific modulation of inner retinal circuits. Additional studies are needed to confirm the preliminary findings to facilitate insights into the retinal mechanism of action with such interventions.

  • Open Access

    Contact lenses with non‑refractive opaque features for paediatric myopia: a randomised, safety pilot trial

    by Ravi C. Bakaraju, Jennie Diec, Daniel Tilia, Klaus Ehrmann, Ranjay Chakraborty


  • Visual performance of spectacle films utilising opaque, non-refractive features for potential myopia management

    by Jennie Diec, Daniel Tilia, Jennifer Sha, Karen Lahav-Yacouel, Klaus Ehrmann, Cathleen Fedtke, Ravi C Bakaraju

    A non-refractive approach for potential myopia management is introduced as spectacle films with opaque features, hypothesised to modulate retinal ganglion cell activity away from the baseline state of the eye. Visual performance of these spectacle films is currently unknown. The aim of this work is to compare the visual performance of spectacle films with opaque non-refractive features (test), MiYOSMART (control: MS), and single vision (control: SV) lenses. This was a prospective, randomised, unmasked, cross-over study where 37 myopic adults (18-42 years) wore each lens for a minimum of 5 days. Subjective visual performance was assessed with a 1-10 numeric rating scale for clarity of vision, vision at night, vision when walking, and overall vision satisfaction and visual acuity (monocular at 6 m and binocular at 6 m and 40 cm). Willingness-to-purchase, based on vision and myopia efficacy, was assessed with a binary Yes/No response. Test and SV were rated higher than MS (p ≤ 0.005) for all subjective ratings, while SV was rated higher than test (p ≤ 0.02) for all ratings except vision when walking (p = 0.11). A higher proportion were willing to purchase both test and SV compared to MS based on vision (p ≤ 0.001), with no difference between test and SV (p = 0.20). A higher proportion were willing to purchase SV compared to MS based on myopia efficacy (p = 0.005), with no difference between test and either control (p > 0.06). SV was significantly better than MS for acuity at 40 cm (p = 0.004) with no differences between lenses for other acuity measurements (p > 0.1). Test offered better subjective visual performance than MS with higher proportions of participants willing to purchase based on vision. Test offered worse subjective visual performance than SV with no differences in willingness-to-purchase questions. SV offered better visual performance than MS and higher proportions of participants willing to purchase for vision or myopia management.


  • Visual performance of phase alteration utilizing sub‐elements lenses for potential myopia management

    by Karen Lahav‐Yacouel, Daniel Tilia, Darrin Falk, Jennie Diec, Jennifer Sha, Cathleen Fedtke, Klaus Ehrmann, Ravi C. Bakaraju

    Purpose: To compare the visual performance (VP) of P.A.U.S.E. spectacle lenses (tests) against defocus incorporated multiple segments (DIMS; control). Methods: This randomized, single‐masked study included 48 participants aged 18–41 years who wore five tests (T1, T2, T4, T5, T6) and DIMS. VP was assessed through the full‐lens and inferior treatment zone. Full‐lens visual‐acuity (VA) based measurements comprised monocular high‐ and low‐contrast VA (HCVA/LCVA) at 6 m and binocular HCVA at 6 m and 40 cm. Assessments through the treatment zone comprised HCVA at 40 cm and subjective ratings (1–10 scale) of near vision‐clarity and ease‐of‐reading. VP was assessed after 3 days of wear (full‐lens) using subjective ratings of vision‐clarity, night‐vision, vision‐while‐walking, eyestrain, overall‐vision‐satisfaction, and willingness‐to‐purchase (yes/no: based on vision and myopia management efficacy). Analyses were performed using linear mixed models and the X 2 test. Significance was set at 5%. Results: Full‐lens binocular HCVA at 40 cm was significantly better with three tests (T2, T4, T5) compared to DIMS ( p ≤ 0.022), whereas there were no differences between any test and DIMS for monocular or binocular HCVA at 6 m ( p > 0.5). Full‐lens monocular LCVA at 6 m was significantly better with DIMS compared to T4 ( p = 0.0057). Through the treatment zone, four tests (T2, T4, T5, T6) were significantly better than DIMS for binocular HCVA at 40 cm ( p < 0.0001), near vision‐clarity ( p ≤ 0.0011) and ease‐of‐reading ( p ≤ 0.0014). T2 was rated significantly higher than DIMS for night‐vision ( p = 0.0085) and overall‐vision‐satisfaction ( p = 0.0495), whereas DIMS was rated higher than T1 for vision‐clarity ( p = 0.0001). There were no significant differences between DIMS and any test for other subjective ratings ( p > 0.07), nor willingness‐to‐purchase based on vision ( p > 0.2) or myopia management efficacy ( p > 0.6). Conclusions: Most of the test lenses achieved better VP through the treatment zone compared to the DIMS control. T2 showed better overall VP compared to DIMS, whereas DIMS showed better overall VP compared to T1.

  • Open Access

    Establishing non-inferiority margins in myopia management contact lens trials with an active control

    by Ravi Chandra Bakaraju, Daniel Tilia

    The myopia control field stands at an ethical crossroads. Withholding proven soft contact lens interventions in control arms of myopia management trials is increasingly viewed as ethically questionable and operationally challenging, particularly given that MiSight 1-day contact lens has demonstrated efficacy in at least four randomised controlled trials. The recent methodological evolution towards non-inferiority trials against an established control rather than a placebo (single vision) is a welcome change. However, this shift raises a critical challenge: setting non-inferiority margins that are both clinically meaningful and statistically robust.

  • Open Access

    Spatio-Temporal Optical Phase Kit for Myopia Control

    by Cathleen Fedtke, Zhi Chen, Daniel Tilia, Lihua Li, Xiaoqin Chen, Klaus Ehrmann, Karen Lahav-Yacouel, Darrin Falk, Fabian Conrad, Kah Ooi Tan, et al.


  • Visual performance of single‐vision contact lenses utilizing opaque, nonrefractive features for potential myopia management

    by Daniel MOptom Tilia, Jennie Boptom Diec, Jennifer Boptom Sha, Karen Moptom Lahav-Yacouel, Klaus Ehrmann, Cathleen Dipl-Ing (FH) Fedtke, Ravi C. BOptom Bakaraju

    SIGNIFICANCE: Contact lenses (CLs) utilizing opaque, nonrefractive features may purposefully modulate retinal ganglion cell activity away from the baseline activity. This is a nonrefractive mechanism that may reduce myopia progression. However, the visual performance of CLs with opaque features is unknown. PURPOSE: This study aimed to compare the visual performance and binocular/accommodative function of CLs with opaque features (test) against MiSight (control‐1) and single‐vision (control‐2) CLs. METHODS: This was a prospective, randomized, unmasked, cross‐over study where 35 myopic CL wearers (18 to 39 years) wore each design for at least 5 days. Visual performance was subjectively assessed using 1 to 10 numeric ratings comprising clarity of vision, lack of ghosting, vision when driving, overall vision satisfaction, and willingness to purchase (yes/no: based on vision and myopia efficacy). Visual acuity measurements comprised monocular and binocular high and low contrast visual acuity at 6 m, and binocular high contrast visual acuity at 70 and 40 cm. Binocular function was assessed using heterophorias at 3 m and 40 cm. Accommodative function was assessed using monocular accommodative facility (MAF) at 40 cm and dynamic monocular accommodative response (AR: 6 m, 70 cm, and 40 cm). RESULTS: Test was rated higher than control‐1 (p0.99). AR was higher with test than both controls at 70 cm (p<0.0001), higher than control‐1 at 40 cm (p0.1). CONCLUSIONS: Compared with control‐1, the test offered better visual performance, a higher proportion of participants willing to purchase, and better MAF. Compared with control‐2, the test offered worse visual performance, but the proportion of participants willing to purchase was not different, and accommodative function was comparable.


  • Open Access

    Visual performance of optical films utilizing Spatio‐Temporal Optical Phase technology

    by Cathleen Dipl-Ing(FH) Fedtke, Daniel MOptom Tilia, Klaus Ehrmann, Jennie Boptom Diec, Karen Moptom Lahav-Yacouel, Darrin MBiomedE Falk, Ravi C. BOptom Bakaraju

    SIGNIFICANCE: Spatio‐Temporal Optical Phase technology utilizes film pairs containing optical elements applied to standard single‐vision spectacle lenses. This technology provides a dynamic optical cue that may have efficacy in reducing the rate of myopia progression, but the visual performance of this technology is unknown. PURPOSE: This study aimed to assess the visual performance of film pairs containing optical elements (tests) and a film pair with no optical elements (control). METHODS: In this randomized, single‐masked, bilateral wear study, 42 participants aged 18 to 40 years wore four test designs (E, F‐1, G, and F‐2) and the control. Subjective data (subjective ratings [1 to 10 scale]: clarity of vision [far‐away, intermediate, near] and vision [at night, while walking, overall satisfaction], and willingness to purchase [yes/no response]) were collected after 3 days. Visual acuity (VA)–based measures (monocular high/low‐contrast VA [6 m], contrast sensitivity [6 m], and binocular high‐contrast VA [6 m and 40 cm]) were collected at dispensing. Visual acuity–based measures were also collected while wearing spectacles with no film. Analyses were performed using linear mixed models and the χ 2 test. Significance was set at 5%. RESULTS: The control performed better than any test for all subjective ratings (mean differences, 1.6 to 3.1 units: p0.08). There were no differences between control and spectacles with no film for any VA‐based measure (p>0.08). CONCLUSIONS: All four test film pairs reduced visual performance compared with control to a degree comparable with other myopia management devices. There was no difference in visual performance between three of the four test film pairs.


  • Open Access

    Comparison of vision performance of spectacles prescribed to 0.05D versus 0.25D steps

    by Tianni Jia, Daniel Tilia, Eric Papas, Fiona Stapleton, Yi Zhen, Fabian Conrad, Jacqueline Tan

    Traditionally, refraction is performed, and spectacles are manufactured in in 0.25D-steps. Trial and spectacle lenses manufactured in smaller increments may allow for a more accurate refraction and...